Fig. 2

Development of OC and tumor size. a Incidence rate (%) of developed OC from 1 to 8 months after DMBA infusion. b The tumor volume (mm³) was measured throughout the experiment. ^* P < 0.05 vs. the OC group; # P < 0.05 vs. the OC + P-MAPA group. c The tumor mass (g) was recorded at the end of treatments. ^* P < 0.05 vs. the OC group